These benefits, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two support the principle of targeting ACKR3 as a novel strategy to modulate the opioid technique, which could open new therapeutic avenues for opioid-relevant Diseases. A study analyze released in Anesthesiology https://victorw946kpu5.tdlwiki.com/user